IP Verse

Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline Modifications

Patent No. EP3135275 (titled "Pharmaceutical Composition Capable Of The Incorporation Of Lenalidomide In Various Crystalline Modifications") was filed by Grindeks on Aug 27, 2015. The application was issued on May 13, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BACHELINFeb 11, 2021HOFFMANN EITLE
HOFFMANN EITLEFeb 11, 2021HOFFMANN EITLE
SYNTHONFeb 11, 2021HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3135275

GRINDEKS
Application Number
EP15182621A
Filing Date
Aug 27, 2015
Status
Revoked
Aug 11, 2023
Publication Date
May 13, 2020
External Links
Slate, Register , Google Patents